GluD1是一个伪装成离子受体的信号传导装置
Jinye Dai1,2, Christopher Patzke3,4, Kif Liakath-Ali3
1Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA. jydai@stanford.edu.
Nature
|June 17, 2021
概括
谷氨酸三角体受体 (GluDs) 通过直接将神经激素-大脑蛋白信号转化为后突触反应来调节NMDA和AMPA受体活性,从而绕过它们的离子作用.
科学领域:
- 神经科学
- 分子生物学
- 突触可塑性
背景情况:
- 离子型谷氨酸三角体受体1和2 (GluD1/2) 通过大脑蛋白与神经激素形成跨突触粘附复合体.
- 这些神经素-脑蛋白-GluD复合体在突触粘附与信号传递中的确切功能尚不清楚.
研究的目的:
- 研究GluD1在海马突触中调解跨突触信号的作用.
- 阐明神经素-脑蛋白复合体调节谷氨酸受体活性的机制.
主要方法:
- 利用海马突触研究突触前神经素和突触后GluD1之间的相互作用.
- 使用最小GluD1/2构造来剖析功能域.
- 分析了NMDA和AMPA受体的不同调节.
主要成果:
- 在不改变突触数量的情况下,与突触后GluD1结合的前突触神经素-脑蛋白复合体控制着谷氨酸受体活性.
- 神经素-1 - 大脑素-2 和神经素-3 - 大脑素-2 复合体通过不同的GluD1 效应信号对NMDA 和AMPA受体进行差异调节.
- 仅含有结合和细胞质域的最小GluD1/2结构调节NMDA和AMPA受体水平,表明其信号作用独立于离子变异功能.
结论:
- GluD1/2作为信号分子, 不仅仅是粘附分子.
- 一种新的转导机制绕过了GluDs的离子热结构,将细胞外神经素-大脑蛋白信号转化为后突触受体反应.
- 神经素结合部位和GluD细胞质域中的特定序列决定了信号特异性.
相关概念视频
G-Protein Gated Ion Channels
5.1K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
5.1K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.1K
Amplifying Signals via Enzymatic Cascade
14.6K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.6K
Activation and Inactivation of G Proteins
8.2K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.2K
Ligand-gated Ion Channels
13.3K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
13.3K
Transducer Mechanism: G Protein–Coupled Receptors
3.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.1K


